Heparin and inflammatory bowel disease [3]

Lancet

Volumn 354, Issue 9184, 1999, Pages 1122-1123

  White, B ^a   Ang, Y S ^a   Mahmud, N ^a   Keeling, P W N ^a   Smith, O P ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10A; HEPARIN; THROMBIN; THROMBOPLASTIN; WARFARIN;

ANTICOAGULATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; ENTERITIS; HUMAN; INFLAMMATION; LETTER; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; TREATMENT FAILURE; ULCERATIVE COLITIS;

EID: 0033604039     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)76915-4     Document Type: Letter

References (5)

1. R Day A Forbes Heparin cell adhesion, and pathogenesis of inflammatory bowel disease Lancet 354 1999 62 65
2. A Lam IT Borda MJ Inwood S Thomson Coagulation studies in ulcerative colitis and Crohn's disease Gastroenterology 68 1975 245 251
3. J Kjeldsen JF Lassen I Brandslund DMO Schaffalitzky Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease Scand J Gastroenterol 33 1998 637 643
4. G Kaplanski M Fabrigoule V Boulay Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-alphaindependent IL-8 secretion and E-selectin expression J Immunol 158 1997 5435 5441
5. A Naldini DH Camey V Bocci Thrombin enhances T cell proliferative responses and cytokine production Cell Immunol 147 1993 367 377